• Inventors:
  • Assignees:
  • Publication Date: December 31, 1969
  • Publication Number:

Abstract

Claims

Description

Topics

Download Full PDF Version (Non-Commercial Use)

Patent Citations (0)

    Publication numberPublication dateAssigneeTitle

NO-Patent Citations (0)

    Title

Cited By (29)

    Publication numberPublication dateAssigneeTitle
    CN-1558759-BJanuary 25, 2012贝林格尔·英格海姆加拿大有限公司病毒聚合酶抑制剂
    EP-1891950-A1February 27, 2008Boehringer Ingelheim (Canada) Ltd.Viral polymerase inhibitors
    EP-1891951-A1February 27, 2008Boehringer Ingelheim (Canada) Ltd.Inhibiteurs de la polymérase virale
    EP-2335700-A1June 22, 2011Boehringer Ingelheim (Canada) Ltd.Inhibiteurs de la polymerase du virus hepatitis C avec une structure heterobicylic
    JP-2006524668-ANovember 02, 2006アヴェンティス ファーマ エス.エー.Aventis Pharma S.A.新規なインドール誘導体、ならびに医薬物質および医薬組成物、特にkdr阻害剤としてのそれらの製造法
    JP-2007535520-ADecember 06, 2007イスティテュート ナヅィオナーレ パー ロ ステュディオ エ ラ クラ デイ ツモリ, ニケム・リサーチ・ソシエタ・ア・レスポンサビリタ・リミタータNiKem Research s.r.l.抗腫瘍作用を有するインドール及びアザインドール誘導体
    JP-2010215617-ASeptember 30, 2010Osaka Univ, Sumitomo Chemical Co Ltd, 住友化学株式会社, 国立大学法人大阪大学Nitrogen-containing organic compound, and organic electroluminescent device using the same
    JP-2012506389-AMarch 15, 2012メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftungアザインドール誘導体
    JP-2013507335-AMarch 04, 2013カロ バイオ アクチェブラーグ新規エストロゲン受容体リガンド
    KR-100807718-B1February 28, 2008한국생명공학연구원Pharmaceutical composition for the prevention and treatment of metabolic disorder containing indole derivatives as an active ingredient
    KR-101392334-B1May 12, 2014한국생명공학연구원신규한 인돌 유도체 또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 함유하는 대사성 질환의 예방 또는 치료용 약학적 조성물
    US-7141574-B2November 28, 2006Boehringer Ingelheim (Canada) Ltd.Viral polymerase inhibitors
    US-7157486-B2January 02, 2007Boehringer Ingelheim (Canada) Ltd.Viral polymerase inhibitors
    US-7803944-B2September 28, 2010Boehringer Ingelheim International GmbhViral polymerase inhibitors
    US-7838537-B2November 23, 2010Boehringer Ingelheim International GmbhViral polymerase inhibitors
    US-7879851-B2February 01, 2011Boehringer Ingelheim International GmbhViral polymerase inhibitors
    US-7888363-B2February 15, 2011Boehringer Ingelheim International GmbhViral polymerase inhibitors
    US-7893084-B2February 22, 2011Boehringer Ingelheim Canada Ltd.Viral polymerase inhibitors
    US-8030309-B2October 04, 2011Boehringer Ingelheim International GmbhViral polymerase inhibitors
    US-8076365-B2December 13, 2011Boehringer Ingelheim International GmbhViral polymerase inhibitors
    US-8710243-B2April 29, 2014Karo Bio AbEstrogen receptor ligands
    US-8906952-B2December 09, 2014Korea Research Institute Of Bioscience & BiotechnologyIndole derivative or pharmaceutically acceptable salt thereof, preparation method thereof, and pharmaceutical composition for preventing or treating metabolic diseases containing same as active ingredient
    WO-03010140-A2February 06, 2003Boehringer Ingelheim (Canada) Ltd.Inhibiteurs de polymerase virale
    WO-03010140-A3July 10, 2003Boehringer Ingelheim Ca Ltd, Pierre Louis Beaulieu, Gulrez Fazal, George Kukolj, Eric Jolicoeur, James Gillard, Marc-Andre Poupart, Jean RancourtInhibiteurs de polymerase virale
    WO-03010141-A2February 06, 2003Boehringer Ingelheim (Canada) Ltd.Hepatitis c virus polymerase inhibitors with a heterobicyclic structure
    WO-03010141-A3May 30, 2003Boehringer Ingelheim Ca Ltd, Pierre Louis Beaulieu, Gulrez Fazal, Sylvie Goulet, George Kukolj, Martin Poirier, Youla S Tsantrizos, Eric Jolicoeur, James Gillard, Marc-Andre Poupart, Jean RancourtHepatitis c virus polymerase inhibitors with a heterobicyclic structure
    WO-2011042473-A2April 14, 2011Karo Bio AbNovel estrogen receptor ligands
    WO-2012150784-A2November 08, 2012한국생명공학연구원Novel indole derivative or pharmaceutically acceptable salt thereof, preparation method thereof, and pharmaceutical composition for preventing or treating metabolic diseases containing same as active ingredient
    WO-2012150784-A3January 03, 2013한국생명공학연구원Novel indole derivative or pharmaceutically acceptable salt thereof, preparation method thereof, and pharmaceutical composition for preventing or treating metabolic diseases containing same as active ingredient